Abigail Girgis

Abigail (Abby) Girgis is a doctoral candidate in the Department of Chronic Disease Epidemiology at the Yale School of Public Health. She is a member of the Cancer Prevention and Control training program, with research interests spanning gynecological cancers, racial and ethnic health disparities, cost-effectiveness analysis, and health outcomes research. Her dissertation explores cervical cancer, aiming to identify critical factors that advance cancer elimination and improve health outcomes across the care continuum, including prevention, early detection, diagnosis, treatment, and survivorship.

Before pursuing her doctoral studies, Abby gained experience in the pharmaceutical industry, with roles at Bristol Myers Squibb, Pfizer, and Johnson & Johnson. Her work spanned immunology epidemiology, chronic disease health economics and outcomes research, and infectious disease global public health. She earned a Master of Public Health (MPH) in Epidemiology with a certificate in Comparative Effectiveness Outcomes Research (CEOR) from Columbia University’s Mailman School of Public Health and a Bachelor of Science (BS) in Global Public Health from New York University.